How have ALIOF shares performed in 2024?

ALIOF's stock was trading at $278.50 on January 1st, 2024. Since then, ALIOF shares have increased by 0.0% and is now trading at $278.50. View the best growth stocks for 2024 here .

How were ALIOF's earnings last quarter?

ALIOF (OTCMKTS:ALIOF) issued its quarterly earnings results on Monday, February, 16th. The company reported $0.87 EPS for the quarter, missing analysts' consensus estimates of $1.09 by $0.22. The company had revenue of $501.50 million for the quarter, compared to analysts' expectations of $546.30 million.

How do I buy shares of ALIOF?

Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ALIOF

ALIOF (ALIOF) Stock Price, News & Analysis

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)

Free ALIOF Stock Alerts

$278.50

0.00 (0.00%)

(As of 09/27/2022)

Compare

Today's Range: $278.50
▼
$278.50
50-Day Range: $278.50
▼
$278.50
52-Week Range: $138.01
▼
$286.30

Volume: N/A
Average Volume: 924 shs
Market Capitalization: $29.89 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ALIOF alerts:

Ad Market Moving Trends

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

About ALIOF Stock (OTCMKTS:ALIOF)

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

ALIOF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ALIOF Stock News Headlines

August 24, 2023 | thestreet.com

5 Things You Must Know Before the Market Opens Friday

May 5, 2023 | msn.com

India goes Digital: 5 major indicators of MASSIVE transformation

See More Headlines

Receive ALIOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/16/2015
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:ALIOF
CUSIP: N/A
CIK: N/A
Web: www.actelion.com
Phone: (161) 565-6565
Fax: 41-61-565-6500
Employees: N/A
Year Founded: 1997

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 107,330,000
Free Float: N/A
Market Cap: $29.89 billion
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Nicholas Franco
Chief Business Development Officer & EVP

Key Competitors

View All Competitors

Should I Buy ALIOF Stock? ALIOF Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in ALIOF:

Actelion Ltd. develops, produces, and markets pharmaceutical drugs, indicating a strong presence in the healthcare industry.
Vanda acquiring rights to Actelion’s multiple sclerosis drug can potentially lead to increased revenue streams for ALIOF.
Recent developments in the pharmaceutical sector have shown promising growth opportunities for companies like ALIOF.
ALIOF's research, development, and manufacturing capabilities position it well for future product innovations and market expansion.
Considering the current stock price of ALIOF can provide insights into its valuation and potential investment returns.

Cons

Investors should be bearish about investing in ALIOF for these reasons:

Market volatility and regulatory challenges in the pharmaceutical industry can impact ALIOF's performance.
Competition from other pharmaceutical companies may pose a threat to ALIOF's market share and profitability.
Global economic conditions and healthcare policies can influence the demand for pharmaceutical products, affecting ALIOF's revenue.
Uncertainties surrounding future drug development and patent expirations could introduce risks to ALIOF's long-term growth prospects.
Investors should carefully assess the industry trends and ALIOF's competitive positioning before making investment decisions.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these ALIOF pros and cons to contact@marketbeat.com.

ALIOF Stock Analysis - Frequently Asked Questions

How have ALIOF shares performed in 2024?: ALIOF's stock was trading at $278.50 on January 1st, 2024. Since then, ALIOF shares have increased by 0.0% and is now trading at $278.50.
View the best growth stocks for 2024 here.
How were ALIOF's earnings last quarter?: ALIOF (OTCMKTS:ALIOF) issued its quarterly earnings results on Monday, February, 16th. The company reported $0.87 EPS for the quarter, missing analysts' consensus estimates of $1.09 by $0.22. The company had revenue of $501.50 million for the quarter, compared to analysts' expectations of $546.30 million.
How do I buy shares of ALIOF?: Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ALIOF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial